跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SOLSINT 75 MICROGRAMOS SOLUCION ORAL EN ENVASE UNIDOSIS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SOLSINT 75 MICROGRAMOS SOLUCION ORAL EN ENVASE UNIDOSIS
Approved
STANDARD
SOLSINT 75 MICROGRAMOS SOLUCION ORAL EN ENVASE UNIDOSIS
Ibsa Farmaceutici Italia S.R.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 16, 2021
Approval ID
d77deca255bdfe71
Company
Ibsa Farmaceutici Italia S.R.L.
Type
Standard
Approval Details
Approval Id
d77deca255bdfe71
Drug Cima Aemps Name
SOLSINT 75 MICROGRAMOS SOLUCION ORAL EN ENVASE UNIDOSIS
Register Number
85619
Holder Company Name
Ibsa Farmaceutici Italia S.R.L.
Marketing Company Name
Instituto Bioquimico Iberico Ibsa S.L.
Authorization Date
2021-02-16
Dosage Form
SOLUCIÓN ORAL EN ENVASE UNIDOSIS
Dose
75 microgramos
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración
Commercialized
Yes
Company Name
Ibsa Farmaceutici Italia S.R.L.
Active Ingredients
LEVOTIROXINA SODICA
0,075 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 16, 2021
Approval ID
d77deca255bdfe71
Type
Standard
Back to CIMA-AEMPS Approvals